Screener
Asset Entities ASST Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Asset Management | $1.51M+1.6% | $1.35M-5.3% | $1.5M+44.4% | $4.19M+326% | $1.49M— | |
| Corporate & Other | $41K+78.3% | $43K— | $17K— | $28K— | $23K— | |
| Medical Device | $1.39M— | $1.37M— | —— | —— | $0— | |
| Total revenues by Product | ||||||
| Investment advisory fees | $1.51M+1.6% | $1.35M-4.9% | $1.5M+44.9% | $4.19M+341% | $1.49M— | |
| Medical device revenues | $1.39M— | $1.37M— | —— | —— | $0— |
FAQ
- How does Asset Entities break its business down?
- Asset Entities (ASST) reports total revenues by business across 3 parts — Asset Management, Corporate & Other and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Asset Entities's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Asset Entities's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
